VOR BIOPHARMA INC (VOR:NASDAQ)
$15.18 1.08 (7.6596%)
Analysed VOR BIOPHARMA INC (VOR:NASDAQ) News Sources
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
30-03-2026
yahoo.com
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
30-03-2026
yahoo.com
Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know
02-04-2026
yahoo.com
Vor Biopharma (VOR) Upgraded to Buy: Here's Why
02-04-2026
yahoo.com
Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?
20-04-2026
yahoo.com
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04-05-2026
yahoo.com
Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade
07-05-2026
yahoo.com
Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
13-05-2026
yahoo.com
Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
14-05-2026
yahoo.com
We're Hopeful That Vor Biopharma (NASDAQ:VOR) Will Use Its Cash Wisely
15-05-2026
yahoo.com
What is the current price of VOR BIOPHARMA INC (VOR:NASDAQ)?
The current price of VOR BIOPHARMA INC (VOR:NASDAQ) is $15.18.
VOR BIOPHARMA INC (VOR:NASDAQ) absolute price change since previous trading day?
The absolute price change of VOR BIOPHARMA INC (VOR:NASDAQ) since the previous trading day is $1.08.
VOR BIOPHARMA INC (VOR:NASDAQ) percentage price change since previous trading day?
The percentage price change of VOR BIOPHARMA INC (VOR:NASDAQ) since the previous trading day is 7.6596%.
What is the most recent average sentiment score for VOR BIOPHARMA INC (VOR:NASDAQ)?
The most recent average sentiment score for VOR BIOPHARMA INC (VOR:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for VOR BIOPHARMA INC (VOR:NASDAQ)?
The most recent sentiment for VOR BIOPHARMA INC (VOR:NASDAQ) is .
SEC-8K** Filing Available For VOR BIOPHARMA INC (VOR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.